194 results on '"Sullivan, Sharon"'
Search Results
2. McBryde, Isabel
3. Immigrant entrepreneurs spice up Grand Junction cuisine
4. Thinking and Working Outside the (Library) Box: From Revolutionary Idea to Strategic Alliance
5. P-286 Impact of hypogammaglobulinemia and immunoglobulin replacement therapy on infection rate in patients with RRMM treated with elranatamab: post-hoc analysis from MagnetisMM-3
6. Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study.
7. P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3
8. P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES
9. S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3
10. Postwar Italian Art History Today: Untying 'the Knot'
11. AN EXTREME ANNUAL PRECIPITATION ANOMALY IN THE PRERADIOSONDE ERA
12. Mental health services for all: Factors influencing desire for mental health services among underresourced adults during COVID-19.
13. Does the practice of heritage as we know it have a future?
14. McBryde, Isabel
15. Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study
16. Issues in Values-Based Management for Indigenous Cultural Heritage in Australia
17. Initial safety results for MagnetisMM-3: A phase 2 trial of elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients (pts) with relapsed/refractory (R/R) multiple myeloma (MM).
18. A matter of principle: Heritage management in Australia and China
19. Book Trade Research and Statistics. Prices of U.S. and Foreign Published Materials; Book Title Output and Average Prices: 2001 Final and 2002 Preliminary Figures; Book Sales Statistics, 2002: AAP Preliminary Estimates; U.S. Book Exports and Imports:2002; Number of Book Outlets in the United States and Canada; Review Media Statistics.
20. Book Trade Research and Statistics. Prices of U.S. and Foreign Published Materials; Book Title Output and Average Prices: 2000 Final and 2001 Preliminary Figures; Book Sales Statistics, 2001: AAP Preliminary Estimates; U.S. Book Exports and Imports: 2001; Number of Book Outlets in the United States and Canada; Review Media Statistics.
21. Book Trade Research and Statistics.
22. Looking After Heritage Places
23. More Unconsidered Trifles? Aboriginal and Archaeological Heritage Values: Integration and Disjunctive in Cultural Heritage Management Practice
24. Tourism: A good servant, but a bad master. Strategies for visitor management at Chengde and Mogao, China
25. Couple Conflict and Intimate Partner Violence during the Early Lockdown of the Pandemic: The Good, the Bad, or Is It Just the Same in a North Carolina, Low-Resource Population?
26. COVID-19 Exposure, Stress, and Mental Health Outcomes: Results From a Needs Assessment Among Low Income Adults in Central North Carolina
27. The begetting of charters: Genesis of the China principles
28. A well-baked Charter
29. World Heritage tentative lists - purpose and background
30. Magnetismm-3: An Open-Label, Multicenter, Non-Randomized Phase 2 Study of Elranatamab (PF-06863135) in Patients with Relapsed or Refractory Multiple Myeloma
31. Obituary
32. Program Offerings for Out-of-School Adults with Learning Disabilities.
33. Key management issues in the conservation and active re/ use of historic buildings. Introductory address. Paper presented at the Australia/ ICOMOS. Conference (1994: Launceston )]
34. Aboriginal sites and the Burra Charter
35. Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)
36. P-307 Efficacy and safety of elranatamab monotherapy in patients with relapsed/refractory multiple myeloma: a post-hoc subgroup analysis from MagnetisMM-3 with modified eligibility criteria
37. Rock art: A cultural treasure at risk
38. Cultural values and cultural imperialism
39. Cisplatin-DNA cross-link models with an unusual type of chirality-neutral chelate amine carrier ligand, N,N'-dimethylpiperazine (Me (sub)2 ppz): Me (sub)2 ppzPt(quanosine monophosphate) (sub)2 adducts that exhibit novel properties
40. Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced women
41. Use of 13C-1H NMR coupling constants to assess the binding of imidazole ring ligands in metals
42. Raymond Lewis (Shoonkley Tiger) Kelly 1938-March 2007
43. The Power Behind Empowerment: Implications for Research and Practice
44. Introduction: Islands of vanishment
45. Student Vocational Organizations. Inservice Instructional Unit IIG.
46. The Weather and Climate of New Mexico: The Land of Meteorological Enchantment
47. The State, People and Archaeologists
48. Appropriated Pasts: Indigenous peoples and the colonial culture of archaeology
49. Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
50. Youth Boost: Leadership program for young people helps anchor one club's rejuvenation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.